(ARDT) Ardent Health Partners - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03980N1072

ARDT: Hospitals, Clinics, Healthcare, Rehabilitation, Surgery

Ardent Health Partners, Inc. (NYSE: ARDT) is a prominent healthcare provider operating a diverse network of hospitals and clinics across the United States. Specializing in acute care, their facilities include rehabilitation and surgical hospitals, addressing a range of medical needs. Established in 2001 and headquartered in Brentwood, Tennessee, Ardent is a subsidiary of EGI-AM Investments, L.L.C., indicating a strategic private equity involvement that may influence their governance and growth strategies.

From a financial standpoint, Ardent boasts a market capitalization of approximately $2.59 billion, positioning it as a significant player in the healthcare sector. The current P/E ratio of 30.76 suggests investor confidence in its growth potential, while the forward P/E of 9.55 hints at anticipated valuation adjustments. The price-to-book ratio of 3.50 indicates a premium on their assets, possibly reflecting strong operational efficiency or brand value. Notably, the price-to-sales ratio of 0.46 underscores efficient revenue generation relative to their market value.

Operating in a competitive landscape, Ardent differentiates itself through a focus on operational excellence and patient-centric care. Their strategic approach to healthcare delivery emphasizes both clinical quality and cost efficiency, positioning them favorably in the market. This operational strategy, coupled with a strong financial profile, makes Ardent an attractive consideration for investors seeking exposure to the healthcare facilities sector.

Additional Sources for ARDT Stock

ARDT Stock Overview

Market Cap in USD 2,591m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception 2024-07-18

ARDT Stock Ratings

Growth Rating -44.0
Fundamental 58.1
Dividend Rating 0.0
Rel. Strength -16.4
Analysts 4.4/5
Fair Price Momentum 10.92 USD
Fair Price DCF 19.26 USD

ARDT Dividends

No Dividends Paid

ARDT Growth Ratios

Growth Correlation 3m -80.8%
Growth Correlation 12m -80.4%
Growth Correlation 5y -80.4%
CAGR 5y -22.10%
CAGR/Max DD 5y -0.53
Sharpe Ratio 12m -0.20
Alpha -26.84
Beta 0.212
Volatility 50.03%
Current Volume 427.4k
Average Volume 20d 435.9k
What is the price of ARDT stocks?
As of April 19, 2025, the stock is trading at USD 12.51 with a total of 427,391 shares traded.
Over the past week, the price has changed by +3.30%, over one month by -11.15%, over three months by -11.28% and over the past year by -22.10%.
Is Ardent Health Partners a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Ardent Health Partners (NYSE:ARDT) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.11 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ARDT as of April 2025 is 10.92. This means that ARDT is currently overvalued and has a potential downside of -12.71%.
Is ARDT a buy, sell or hold?
Ardent Health Partners has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy ARDT.
  • Strong Buy: 6
  • Buy: 2
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ARDT stock price target?
According to ValueRays Forecast Model, ARDT Ardent Health Partners will be worth about 11.8 in April 2026. The stock is currently trading at 12.51. This means that the stock has a potential downside of -5.68%.
Issuer Forecast Upside
Wallstreet Target Price 22.8 82.1%
Analysts Target Price 22.8 82.1%
ValueRay Target Price 11.8 -5.7%